CTRANEUTRAL

P/E Ratio

14.7x

Updated 488h ago

Sector Performance

19th percentile

CTRA

14.7x

Sector Median

24.7x

Sector Avg

36.0x

📊

Deep Analysis

The P/E ratio of 14.7x means investors pay $14.70 for every $1 of CTRA's past-year earnings, a common measure of how cheap or expensive a stock is relative to its profits.

This ratio sits well below the sector median of 24.9x, placing CTRA in the 16th percentile among its peers—meaning only 16% of sector stocks are cheaper on this basis. Over the past eight quarters, the metric has been stable, with the most recent quarter dropping 4.4% from the prior quarter (15.3x to 14.7x); year-over-year change is not available for comparison. The combination of a low valuation relative to sector peers and a stable-to-slightly-declining trend suggests limited downside risk from further compression, but also no immediate catalyst for re-rating. The NEUTRAL verdict is supported: the discounted P/E offers a margin of safety, yet the lack of upward momentum in the metric implies the market sees no strong reason to bid the stock higher.

Frequently Asked Questions

What does the P/E Ratio tell investors about CTRA?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are CTRA's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master CTRA's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full CTRA research report

Free account — no credit card

CTRA

14.7x

Sector Median

24.7x

Sector Avg

36.0x

How CTRA's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.